Transforming Cardiac Care Through Superior MRI Technology

Watch video

MyoHealth® is a breakthrough risk score that uses the MyoStrain software to enable rapid, non-invasive cardiac MRI scans to detect early signs of heart dysfunction—before symptoms arise. In just 10 minutes, clinicians gain detailed insights into patients’ heart health, helping them assess risk, personalize treatment, and monitor patient healthcare management.

Years of innovation
0
Institutions with clinical experience
0 +
Publications
0 +
Subjects tested
0 K+

WHO WE ARE

Fast, accurate, reproducible diagnostic test to quantify heart health using MRI.

MYOCARDIAL SOLUTIONS VISION IS

To bring new innovative diagnostic technologies for the early detection of cardiac dysfunction to improve population health management by personalizing cardiac and oncology care.

More information

What Myocardial solutions offers

Myocardial Solutions’ (MSI) mission is to give cardiac and oncology patients control over their heart health

More information

Workflow

Our workflow is designed to ensure seamless integration of MyoStrain® technology into clinical practice, providing efficient and accurate cardiac assessments.

10 Min MRI 
without contrast

Comprehensive Diagnostic Report

MyoHealth® Risk Score  

WHAT IS MYOSTRAIN®

A Rapid quantitative Heart Health Assessment test

Watch video
Download report

Benefits of using MyoStrain®

Rapid test

12 heart beats acquisition

High Reproducibility

Reports intramyocardial contraction of 48 segments of left and right ventricles

Clinical Value

Aids physicians to early detect patients at-risk of cardiac dysfunction

Enhanced Patient Experience

Safe and non-invasive test

APPLICATIONS

Clinical Applications of MyoStrain® for Cardiovascular Health

CARDIO ONCOLOGY

EARLY DETECTION

HEART FAILURE MANAGEMENT

STRESS TESTING
CAD

Learn about MyoStrain

MYOSTRAIN® FOR DOCTORS
MYOSTRAIN® FOR PATIENTS

Myostrain Clinical Sites near you

Physician Testimonials

Read how our cardiology services have helped patients recover, reach their goals, and live healthier lives. Your success could be next!

“MyoStrain is the first test that provides physicians with the inherent visibility to monitor the effects of cardiotoxicity from cancer therapy and promote the use of cardio-protective drugs on the heart. This is a game-changing technology that could revolutionize how we carefully monitor patients undergoing cancer treatment.”
Daniel Lenihan, MDProfessor of Cardiovascular Medicine, Cardio-oncology Center of Excellence Director at Washington University School of Medicine in St. Louis
“MyoStrain provides a quantitative, single-heartbeat MRI test that allows us to detect patient heart risk without radiation or contrast injections, and may therefore offer a proactive, patient-centric tool to effectively detect and manage patients at risk of heart failure.”
Sebastian Kelle, MD, PhDHead of Cardiac MRI at the Berlin Heart Institute
“MyoStrain was able to both identify and classify cardiac risk in patients who did not exhibit any cardiovascular symptoms and where traditional metrics could not. These are substantial findings that could profoundly impact the standard of care in cardiology and cardio-oncology.”
Grigorios Korosoglou, MDChief of Cardiology & Vascular Medicine at GRN Hospital in Weinheim, Germany
“MyoStrain bridges a crucial gap in oncology and cardiology care. Thanks to the advances in oncology care, cancer is more treatable now than ever before… there is increasing concern about the potential side effects of these treatments, including the impact they may have on the heart.”
Susan Dent, MDMedical Oncologist, Cardio-oncology Co-director at Duke Cancer Institute
“With MyoHealth, we are able to minimize the scan time and minimize the analysis time… This new cardiac MRI technique allows us to better implement cardiac MRI in our daily practice.”
Teresa López, MDDirector of Cardiac Imaging and Cardio-Oncology at La Paz University Hospital in Madrid, Spain
“MyoStrain offers the visibility needed to help clinicians assess early asymptomatic dysfunction in our patients. It uses a unique and highly sensitive technique to acquire segmental strain, which provides us both the ability to detect and subsequently categorize these patients into risk groups.”
Henning Steen, MD, PhDHead of Cardiac MRI at Marien Hospital in Hamburg, Germany
“MyoStrain holds promise for identifying patients early in their myocardial disease trajectory who are at risk for declining contractility over time and may benefit from early therapeutic intervention.”
Deborah Kwon, MDDirector of Cardiac MRI, Cleveland Clinic
“The hyperventilation/breath-hold maneuver combined with MyoStrain/MyoStress provides a fast and safe scan procedure… designed to help advance ischemia detection, improve workflow efficiency and enhance the overall patient experience.”
Marco Ochs, MDCardiologist at Theresien Hospital in Mannheim, Germany
“MyoStrain is an excellent candidate to deliver standardized, accurate and validated tools, allowing us to detect small differences on the individual basis and guide prevention of patients at risk of heart failure during or post-treatment.”
Valentina Püntmann, MDAssociate Professor at the University of Frankfurt
“We adapted the hyperventilation/breath-hold maneuver with MyoStrain to help overcome limitations of stress testing, providing a fast, safe and non-invasive approach to improve cardiovascular assessment of patients suspected of coronary artery disease.”
Matthias Friedrich, MDProfessor of Medicine and Chief of Cardiovascular Imaging at McGill University Health Centre
“MyoStrain is a promising technology to help ensure cardiac health in patients receiving potentially cardio-toxic cancer therapies.”
Lauren Baldassarre, MDCardiologist, Yale School of Medicine
“Changes in circumferential and longitudinal strain during intermediate-dose dobutamine infusion by MyoStrain can unmask CAD prior to the development of any quantifiable alteration in wall thickening.”
Amit Patel, MDDirector of Cardiovascular Magnetic Resonance and Computed Tomography at University of Chicago
“The ability to evaluate progression of LV strain abnormalities with MyoStrain may help identify changes in LV function before the onset of a reduction in LVEF and development of heart failure.”
Ronald Mikolich, MDProfessor of Internal Medicine, NEOMED

FAQs

MyoStrain is a new rapid and MRI heart scan performed in under 10 minutes. It measures how the heart muscle contracts, helping physicians detect early heart dysfunction before symptoms appear.

Heart disease often develops silently. MyoStrain helps  allows doctors to identify early, reversible changes in heart function so treatment can begin before permanent damage occurs. It enables true prevention and personalized care. 

MyoStrain is available to those who want to know more about their heart health and are eligible for an MRI scan. Currently, MyoStrain is being used primarily to detect early asymptomatic heart dysfunction in patients who have risk factors commonly associated with heart disease, such as hypertension or diabetes, as well as recovered COVID-19 patients and cancer survivors.

The MyoStrain scan is a simple and straightforward procedure. First, a technologist will assist you into the scanner. MyoStrain will perform a twelve-heartbeat scan and collect 6 encoded images of your heart. MyoStrain will then analyze the images and generate a report. This report contains a MyoHealth score, which is a single number calculated based on the percentage of normally functioning heart tissue. A certified MyoStrain physician will then reach out to you afterwards to review your score and results.

MyoStrain provides a highly accurate and sensitive assessment that has been documented in more than 500 peer-reviewed publications. Studies show that MyoStrain is able to help physicians detect and proactively manage the early asymptomatic effects of diseases, drugs and treatments on the heart, and where traditional heart tests could not. Learn more

The average MyoStrain scan is complete in under 10 minutes.

MyoStrain is a safe and non-invasive procedure that is performed without the use of radiation, contrast agents, pharmacological stressors, needle injections, or breath holding. However, not everyone is eligible for an MRI scan. See who can undergo an MRI scan here.

After your MyoStrain scan, a certified MyoStrain physician will contact you to go over your scan results. Depending on your MyoHealth score, your certified MyoStrain physician may prescribe you with a personalized treatment plan and/or schedule a follow-up scan to monitor for any changes in your heart health.

Your MyoStrain report contains critical information about your heart health, including your personalized MyoHealth score, which used together with a certified physician’s clinical judgement, provides actionable information to decide the best treatment plan for you.

The MyoHealth Score is a single number representing the percentage of your heart muscle that is functioning normally. It is calculated by dividing the number of normal segments by the total number of left-ventricular segments. This allows certified MyoStrain physician to track subtle changes in your heart health early and monitor the effectiveness of your treatment over time.

MyoStrain is typically covered by Medicare and may be covered by other major insurers. Depending on your plan, there may also be a co-pay to receive the scan.

MyoStrain is a new rapid and accurate MRI heart scan performed in under 10 minutes. It’s a first-of-its-kind heart health assessment that directly measures the heart’s ability to contract, which may help physicians to detect heart dysfunction early and may help them prevent adverse events before symptoms of heart damage occur. This is a transformative new approach to heart care, as it allows physicians to focus on optimizing your treatment and protecting the heart long-term.

MyoStrain measures the heart’s ability to contract effectively across 48 segments of the heart. If any individual segment is weak, or isn’t contracting properly, doctors can identify the affected area quickly and start treating it before the issue spreads to other parts of the heart.  

Yes, MyoStrain has undergone a rigorous validation process by the FDA and has received FDA 510(k) clearance as of February 2019. Learn more

Magnetic resonance imaging (MRI) is an advanced diagnostic imaging technique that uses powerful magnetic fields to produce high-resolution images of your body’s soft tissue.

No, MRIs do not use X-rays or any form of ionizing radiation.

Although MRIs are completely safe and painless, there are some people who should not undergo an MRI scan, or will need special accommodations to receive an MRI scan, such as those who: 

  • Have a cardiac pacemaker
  • Have a surgical implant, hearing aid, body monitor or some other implanted medical device
  • Who have ever held a job in a metal-working industry or have been exposed to metallic dust, splinters
  • Suffer from claustrophobia
  • Weigh more than 300 pounds
  • Are pregnant or think they might be